|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rosenbaum MA and McHenry CR: Contemporary
management of papillary carcinoma of the thyroid gland. Expert Rev
Anticancer Ther. 9:317–329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brito JP, Hay ID and Morris JC: Low risk
papillary thyroid cancer. BMJ. 348:g30452014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Annibaldi A and Widmann C: Glucose
metabolism in cancer cells. Curr Opin Clin Nutr Metab Care.
13:466–470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kraegen EW, Sowden JA, Halstead MB, Clark
PW, Rodnick KJ, Chisholm DJ and James DE: Glucose transporters and
in vivo glucose uptake in skeletal and cardiac muscle: Fasting,
insulin stimulation and immunoisolation studies of GLUT1 and GLUT4.
Biochem J. 295:287–293. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ciavardelli D, Bellomo M, Consalvo A,
Crescimanno C and Vella V: Metabolic alterations of thyroid cancer
as potential therapeutic targets. Biomed Res Int. 2017:25450312017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamasaki T, Seki N, Yoshino H, Itesako T,
Yamada Y, Tatarano S, Hidaka H, Yonezawa T, Nakagawa M and Enokida
H: Tumor-suppressive microRNA-1291 directly regulates glucose
transporter 1 in renal cell carcinoma. Cancer Sci. 104:1411–1419.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang YF, Zhang Y, Liu CX, Huang J and
Ding GH: microRNA-125b contributes to high glucose-induced reactive
oxygen species generation and apoptosis in HK-2 renal tubular
epithelial cells by targeting angiotensin-converting enzyme 2. Eur
Rev Med Pharmacol Sci. 20:4055–4062. 2016.PubMed/NCBI
|
|
12
|
Lang BHH, Lo CY, Chan WF, Lam KY and Wan
KY: Staging systems for papillary thyroid carcinoma: A review and
comparison. Ann Surg. 245:366–378. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guan Y, Yao H, Zheng Z, Qiu G and Sun K:
miR-125b targets BCL3 and suppresses ovarian cancer proliferation.
Int J Cancer. 128:2274–2283. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Yan LX, Wu QN, Du ZM, Chen J,
Liao DZ, Huang MY, Hou JH, Wu QL, Zeng MS, et al: miR-125b is
methylated and functions as a tumor suppressor by regulating the
ETS1 proto-oncogene in human invasive breast cancer. Cancer Res.
71:3552–3562. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ
and White RW: miR-125b promotes growth of prostate cancer xenograft
tumor through targeting pro-apoptotic genes. Prostate. 71:538–549.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao
Y, Feng Y, Li L, Wang Y, Liu X, et al: MicroRNA-143 (miR-143)
regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol
Chem. 287:23227–23235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao X, Huang X, Ye F, Chen B, Song C, Wen
J, Zhang Z, Zheng G, Tang H and Xie X: The miR-34a-LDHA axis
regulates glucose metabolism and tumor growth in breast cancer. Sci
Rep. 6:217352016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen B, Liu Y, Jin X, Lu W, Liu J, Xia Z,
Yuan Q, Zhao X, Xu N and Liang S: MicroRNA-26a regulates glucose
metabolism by direct targeting PDHX in colorectal cancer cells. BMC
Cancer. 14:4432014. View Article : Google Scholar : PubMed/NCBI
|
